Dr. Jun Gong, medical oncologist of the Gastrointestinal Disease Research Group, Pancreatic Cancer Research Group, and Urologic Oncology Program in the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, discusses the importance of ctDNA and MRD testing with the expanded access program during COVID-19.

Posted on October 7, 2020
430 views